Fred Callori

CIK: 0001843393

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)5 (62.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

LONA

LeonaBio, Inc.

Director

ATXS

Astria Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

LONA
LeonaBio, Inc.
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
2.3K shares-
LONA
LeonaBio, Inc.
May 5, 2026
Award(A)
Stock Option (Right to Buy)
Direct
56K shares-
ATXS
Astria Therapeutics, Inc.
Jan 23, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
8.3K shares-
ATXS
Astria Therapeutics, Inc.
Jan 23, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
14.1K shares-
ATXS
Astria Therapeutics, Inc.
Jan 23, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
14.1K shares-
ATXS
Astria Therapeutics, Inc.
Jan 23, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
26.6K shares-
ATXS
Astria Therapeutics, Inc.
Jan 23, 2026
Disposition(D)
Stock Option (Right to Buy)
Direct
14.2K shares-
ATXS
Astria Therapeutics, Inc.
Jun 11, 2025
Award(A)
Stock Option (Right to Buy)
Direct
26.6K shares-

		Type	Shares	Price		Ownership
Jun 23, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	2,333	-	-	Direct
May 5, 2026	LONA LeonaBio, Inc.	Award(A) Stock Option (Right to Buy)	56,000	-	-	Direct
Jan 23, 2026	ATXS Astria Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	8,333	-	-	Direct
Jan 23, 2026	ATXS Astria Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	14,100	-	-	Direct
Jan 23, 2026	ATXS Astria Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	14,100	-	-	Direct
Jan 23, 2026	ATXS Astria Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	26,550	-	-	Direct
Jan 23, 2026	ATXS Astria Therapeutics, Inc.	Disposition(D) Stock Option (Right to Buy)	14,166	-	-	Direct
Jun 11, 2025	ATXS Astria Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	26,550	-	-	Direct

1-8 of 8 transactions

About Callori Fred

Callori Fred (SEC CIK 0001843393) files insider reports with the SEC as Director of LeonaBio, Inc. (LONA) and Director of Astria Therapeutics, Inc. (ATXS).

Signal8 holds 5 ownership filings by Callori Fred (1 Form 3, 4 Form 4), filed between Jun 12, 2025 and Jun 24, 2026. Those filings report 8 transactions, from Jun 11, 2025 to Jun 23, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Callori Fred's filings is in BOTHELL, WA.

Recent filings by Callori Fred

Jun 23, 2026: Grant or award of LONA derivative securities (Form 4, code A).
May 5, 2026: Grant or award of LONA derivative securities (Form 4, code A).
Jan 23, 2026: Disposition to issuer transactions of ATXS derivative securities (5 lines, Form 4, code D).
Jun 11, 2025: Grant or award of ATXS derivative securities (Form 4, code A).

Other insiders filing for LeonaBio, Inc. (LONA)

How to read Form 4 transaction codes